Authors: MERRITT JA CLAYMAN GL SWISHER S NEMUNAITIS J ELNAGGAR A GINSBERG L LAWRENCE D TIMMONS T HENDERSON Y FREDERICK M CONNORS D HUTCHISON A BRUSO P ROTH JA SHULKIN A WEILL D WAIT J

Citation: Ja. Merritt et al., CLINICAL-PHASE-I EXPERIENCE WITH INGN-201 (AD-P53) IN NONSMALL CELL LUNG-CANCER AND HEAD AND NECK-CANCER, Cancer gene therapy, 4(6), 1997, pp. 1-1

Authors: HENDERSON Y DEISSEROTH AB

Citation: Y. Henderson et Ab. Deisseroth, A POTENTIAL MECHANISM FOR THE RESISTANCE OF INTERFERON-ALPHA TREATMENT IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS, Journal of investigative medicine, 44(3), 1996, pp. 232-232

Authors: HENDERSON Y DEISSEROTH AB

Citation: Y. Henderson et Ab. Deisseroth, ALTERED PATTERNS OF ACTIVATION OF JAK KINASES BY INTERFERONS IN CHRONIC MYELOGENOUS LEUKEMIA (CML) CELLS, Blood, 86(10), 1995, pp. 2654-2654